Evidence map›Paper›PMID 29528423›Full record

ArticleThe Journal of infectious diseases2018

A Role for Salivary Peptides in the Innate Defense Against Enterotoxigenic Escherichia coli.

Jeffrey W Brown, Arwa Badahdah, Micah Iticovici, Tim J Vickers, David M Alvarado, Eva J Helmerhorst, Frank G Oppenheim, Jason C Mills, Matthew A Ciorba, James M Fleckenstein and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. EnterotoxigenicGut microbes
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jeffrey W BrownDepartment of Physiology and Biophysics, Boston University School of Medicine, Massachusetts.
Arwa BadahdahDepartment of Periodontology and Oral Biology, Boston University Goldman School of Dental Medicine, Massachusetts.
Micah IticoviciDivision of Gastroenterology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
Tim J VickersDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
David M AlvaradoDivision of Gastroenterology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
Eva J HelmerhorstDepartment of Molecular and Cell Biology, Boston University, Massachusetts.
Frank G OppenheimDepartment of Molecular and Cell Biology, Boston University, Massachusetts.
Jason C MillsDivision of Gastroenterology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
Matthew A CiorbaDivision of Gastroenterology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
James M FleckensteinDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
Esther BullittDepartment of Physiology and Biophysics, Boston University School of Medicine, Massachusetts.
Boston University · USWashington University in St. Louis · USVeterans Health Administration · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
CLINICAL/LABORATORY TRAINING ACADEMIC GASTROENTEROLOGYT32DK007130 · NIDDK · WASHINGTON UNIVERSITY · PI MATTHEW AARON CIORBA · 1986 to 2026
$8.3M
Novel Antigen Identification for an Enterotoxigenic E. coli VaccineR01AI089894 · NIAID · WASHINGTON UNIVERSITY · PI Zachary T. Berndsen, James Michael Fleckenstein · 2010 to 2026
$7.4M
REGULATION OF ATROPHY-INDUCED PROGENITOR CELLS IN THE GASTRIC CORPUSR01DK094989 · NIDDK · WASHINGTON UNIVERSITY · PI Jason C Mills · 2012 to 2026
$6.1M
Pediatric Gastroenterology Research Training ProgramT32DK077653 · NIDDK · WASHINGTON UNIVERSITY · PI PHILLIP I TARR · 2007 to 2026
$5.8M
MECHANISMS OF CHIEF CELL DEDIFFERENTIATIONR01DK105129 · NIDDK · WASHINGTON UNIVERSITY · PI Jason C Mills · 2015 to 2026
$5.4M
MICROBICIDAL SALIVARY HISTIDINE-RICH PROTEINSR01DE007652 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI OPPENHEIM, FRANK G · 1986 to 2012
$3.9M
Salivary Proteins in Dental IntegumentsR01DE005672 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI OPPENHEIM, FRANK G · 1985 to 2009
$3.1M
STRUCTURE/FUNCTION OF BACTERIAL ADHESION PILIR01GM055722 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BULLITT, ESTHER · 1998 to 2009
$2.1M
Molecular Microbiology of Enterotoxigenic E. coli Pathogen-Host InteractionsR01AI126887 · NIAID · WASHINGTON UNIVERSITY · PI FLECKENSTEIN, JAMES MICHAEL · 2016 to 2020
$1.6M
Oral microbial enzymes for the treatment of celiac diseaseK02AI101067 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HELMERHORST, EVA JOSEPHINE · 2013 to 2017
$509k
NCI NIH HHS P30 CA091842NCI NIH HHS R21 CA206039NIAID NIH HHS K02 AI101067NIAID NIH HHS R01 AI089894NIAID NIH HHS R01 AI126887NIDCR NIH HHS F31 DE005672NIDCR NIH HHS R01 DE005672NIDCR NIH HHS R01 DE007652NIDCR NIH HHS R37 DE005672NIDDK NIH HHS P30 DK052574NIDDK NIH HHS R01 DK094989NIDDK NIH HHS R01 DK105129NIDDK NIH HHS T32 DK007130NIDDK NIH HHS T32 DK077653NIGMS NIH HHS R01 GM055722
6 · The paper itself

Abstract

Background: Diarrheal disease from enterotoxigenic Escherichia coli (ETEC) causes significant worldwide morbidity and mortality in young children residing in endemic countries and is the leading cause of traveler's diarrhea. As ETEC enters the body through the oral cavity and cotransits the digestive tract with salivary components, we hypothesized that the antimicrobial activity of salivary proteins might extend beyond the oropharynx into the proximal digestive tract. Results: Here, we show that the salivary peptide histatin-5 binds colonization factor antigen I pili, thereby blocking adhesion of ETEC to intestinal epithelial cells. Mechanistically, we demonstrate that histatin-5 stiffens the typically dynamic pili, abolishing their ability to function as spring-like shock absorbers, thereby inhibiting colonization within the turbulent vortices of chyme in the gastrointestinal tract. Conclusions: Our data represent the first report of a salivary component exerting specific antimicrobial activity against an enteric pathogen and suggest that histatin-5 and related peptides might be exploited for prophylactic and/or therapeutic uses. Numerous viruses, bacteria, and fungi traverse the oropharynx to cause disease, so there is considerable opportunity for various salivary components to neutralize these pathogens prior to arrival at their target organ. Identification of additional salivary components with unexpectedly broad antimicrobial spectra should be a priority.

Indexed as

Immunity, InnateAntimicrobial Cationic PeptidesCaco-2 CellsEnterotoxigenic Escherichia coliFimbriae ProteinsHumansSalivary Proteins and PeptidesAntimicrobial Cationic Peptidescolonization factor antigensFimbriae ProteinsSalivary Proteins and Peptides

Identifiers

PMID29528423
PMCPMC5894089
OpenAlexW2791509805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.